When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Doença do refluxo gastroesofágico

Last reviewed: 22 Aug 2025
Last updated: 28 Jan 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • pirose
  • regurgitação ácida
Full details

Other diagnostic factors

  • disfagia
  • distensão abdominal/saciedade precoce
  • laringite
  • globus
  • erosão do esmalte
  • halitose
  • dispepsia
Full details

Risk factors

  • história familiar de pirose ou DRGE
  • idade avançada
  • hérnia de hiato
  • obesidade
  • uso de medicamentos redutores do tônus do esfíncter esofágico inferior (EEI)
  • estresse psicológico
  • asma
  • uso de anti-inflamatórios não esteroidais (AINEs)
  • tabagismo
  • consumo de bebidas alcoólicas
  • miotomia endoscópica peroral (POEM)
  • fatores alimentares
  • gestação
Full details

Diagnostic investigations

1st investigations to order

  • teste do inibidor da bomba de prótons (IBP)
Full details

Investigations to consider

  • endoscopia digestiva alta (EDA)
  • pH-metria (monitoramento do potencial hidrogeniônico [pH]) ambulatorial
  • manometria esofágica
  • teste combinado de pHmetria com impedância
  • esofagografia baritada
  • endoscopia por cápsula esofágica
Full details

Emerging tests

  • sonda de imagem do lúmen funcional endoluminal

Treatment algorithm

ACUTE

apresentação inicial

ONGOING

não gestante: com resposta clínica a inibidor da bomba de prótons

não gestante: resposta incompleta a inibidor da bomba de prótons

gestante: sintomas não tratáveis ou doença do refluxo complicada

Contributors

Authors

Marc J. Zuckerman, MD

Professor of Medicine

Chief of Division of Gastroenterology

Texas Tech University Health Sciences Center

El Paso

TX

Disclosures

MJZ is on the speakers bureau for Phathom Pharmaceuticals.

Andres F. Carrion, MD

Associate Professor of Clinical Medicine

Division of Gastroenterology and Hepatology

University of Miami

Miami

FL

Disclosures

AFC declares that he has no competing interests.

Acknowledgements

Dr Marc J. Zuckerman and Dr Andres F. Carrion would like to gratefully acknowledge Dr Sheila Feit and Dr Mohamed Othman, previous contributors to this topic.

Disclosures

SF declares that she has no competing interests. MO has acted as a consultant for Olympus.

Peer reviewers

Lars Aabakken, MD

Professor of Medicine

Chief of GI Endoscopy

Rikshospitalet University Hospital

Oslo

Norway

Disclosures

LA declares that he has no competing interests.

Lise Lotte Gluud, MD, DMSc

Consultant

Department of Internal Medicine

Copenhagen University Hospital

Hellerup

Denmark

Disclosures

LLG declares that she has no competing interests.

Gary W. Falk, MD, MS

Professor of Medicine

Department of Gastroenterology & Hepatology

Center for Swallowing & Esophageal Disorders

Cleveland Clinic

Cleveland

OH

Disclosures

GWF has received fees from: AstraZeneca (consultant, speakers bureau, grant support); Takeda (grant support); Pentax (speaker, travel); Wyeth (consultant); and C2 Therapeutics (consultant).

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56.Full text  Abstract

Muthusamy VR, Lightdale JR, Acosta RD, et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305-10.Full text  Abstract

Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-15. Abstract

Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016 Feb;14(2):175-82.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Doença do refluxo gastroesofágico images
  • Differentials

    • Síndrome coronariana aguda
    • Angina estável
    • Distúrbio esofágico funcional/pirose funcional
    More Differentials
  • Guidelines

    • ACR practice parameter for the performance of esophagrams and upper gastrointestinal examinations in adults
    • Clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease
    More Guidelines
  • Patient information

    Refluxo gastroesofágico, pirose e doença do refluxo gastroesofágico (DRGE)

    Doença do refluxo gastroesofágico (DRGE): perguntas para fazer ao seu médico

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer